Bridges Investment Management Inc. lifted its stake in Stryker Corporation (NYSE:SYK) by 46.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,216 shares of the medical technology company’s stock after buying an additional 700 shares during the period. Bridges Investment Management Inc.’s holdings in Stryker were worth $343,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. WFG Advisors LP lifted its stake in shares of Stryker by 1.6% in the second quarter. WFG Advisors LP now owns 2,041 shares of the medical technology company’s stock valued at $283,000 after buying an additional 32 shares during the period. Advisory Services Network LLC lifted its stake in shares of Stryker by 1.8% in the second quarter. Advisory Services Network LLC now owns 3,398 shares of the medical technology company’s stock valued at $472,000 after buying an additional 59 shares during the period. Linscomb & Williams Inc. lifted its stake in shares of Stryker by 1.2% in the second quarter. Linscomb & Williams Inc. now owns 10,486 shares of the medical technology company’s stock valued at $1,455,000 after buying an additional 121 shares during the period. Cornerstone Capital Management Holdings LLC. lifted its stake in shares of Stryker by 0.3% in the second quarter. Cornerstone Capital Management Holdings LLC. now owns 53,572 shares of the medical technology company’s stock valued at $7,434,000 after buying an additional 135 shares during the period. Finally, Scotia Capital Inc. lifted its stake in shares of Stryker by 4.5% in the second quarter. Scotia Capital Inc. now owns 5,590 shares of the medical technology company’s stock valued at $776,000 after buying an additional 243 shares during the period. Institutional investors and hedge funds own 74.71% of the company’s stock.
Shares of Stryker Corporation (SYK) opened at $159.87 on Friday. The firm has a market cap of $59,395.74, a P/E ratio of 59.65, a PEG ratio of 2.28 and a beta of 0.70. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.59 and a current ratio of 2.29. Stryker Corporation has a fifty-two week low of $124.89 and a fifty-two week high of $170.00.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, April 30th. Stockholders of record on Thursday, March 29th will be issued a dividend of $0.47 per share. This represents a $1.88 annualized dividend and a dividend yield of 1.18%. The ex-dividend date of this dividend is Wednesday, March 28th. Stryker’s payout ratio is 70.15%.
Several equities research analysts recently weighed in on SYK shares. Wells Fargo & Co increased their target price on shares of Stryker from $160.00 to $166.00 in a research note on Friday, October 27th. SunTrust Banks reissued a “buy” rating and issued a $161.00 price target on shares of Stryker in a research report on Friday, November 17th. Cowen set a $166.00 price target on shares of Stryker and gave the stock a “buy” rating in a research report on Sunday, October 29th. ValuEngine raised shares of Stryker from a “hold” rating to a “buy” rating in a research report on Tuesday, November 14th. Finally, Canaccord Genuity increased their price target on shares of Stryker from $155.00 to $162.00 and gave the stock a “buy” rating in a research report on Friday, October 27th. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and fourteen have given a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $162.50.
In other news, Director Howard E. Cox, Jr. sold 7,400 shares of the firm’s stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of $164.09, for a total transaction of $1,214,266.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP William E. Berry, Jr. sold 1,306 shares of the firm’s stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $164.42, for a total transaction of $214,732.52. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 16,840 shares of company stock valued at $2,749,989. Company insiders own 7.40% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This piece of content was first published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece of content can be accessed at https://www.chaffeybreeze.com/2018/02/18/bridges-investment-management-inc-grows-position-in-stryker-corporation-syk.html.
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.